| Cell line name |
WSU-ALCL |
|---|
| Accession |
CVCL_A036 |
|---|
| Resource Identification Initiative |
To cite this cell line use: WSU-ALCL (RRID:CVCL_A036) |
|---|
| Comments |
Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a malignant pleural effusion of a 18 year old patient with primary refractory anaplastic large cell lymphoma.
Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00284.
Population: Caucasian.
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Cell type: T-cell; CL=CL_0000084. |
|---|
| Sequence variations |
- Gene fusion; HGNC; 13222; BCL11B + HGNC; 2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
- Mutation; HGNC; 16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
- Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
|
|---|
| Disease |
Childhood T acute lymphoblastic leukemia (NCIt: C7953)
Precursor T-cell acute lymphoblastic leukemia (ORDO: Orphanet_99861) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Hierarchy |
Parent: CVCL_0207 (CCRF-CEM) |
|---|
| Sex of cell |
Female |
|---|
| Age at sampling |
3Y11M |
|---|
| Category |
Cancer cell line |
|---|
| Web pages |
https://iclac.org/wp-content/uploads/Cross-Contaminations_v12_distribution.xlsx |
|---|
| Publications | CLPUB00128
Al-Katib A., Abubakr Y.A., Mohamed A.N., Maki A., Diurec Z.
Multiple mechanisms of drug resistance in anaplastic large cell lymphoma.
Blood 84 Suppl. 1:638a-638a(1994) PubMed=8558920
Dirks W.G., Zaborski M., Jager K., Challier C., Shiota M., Quentmeier H., Drexler H.G.
The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.
Leukemia 10:142-149(1996) PubMed=12592342; DOI=10.1038/sj.leu.2402799
Drexler H.G., Dirks W.G., Matsuo Y., MacLeod R.A.F.
False leukemia-lymphoma cell lines: an update on over 500 cell lines.
Leukemia 17:416-426(2003) PubMed=20143388; DOI=10.1002/ijc.25242
Capes-Davis A., Theodosopoulos G., Atkin I., Drexler H.G., Kohara A., MacLeod R.A.F., Masters J.R.W., Nakamura Y., Reid Y.A., Reddel R.R., Freshney R.I.
Check your cultures! A list of cross-contaminated or misidentified cell lines.
Int. J. Cancer 127:1-8(2010) |
|---|
| Cross-references |
|---|
| Cell line databases/resources |
cancercelllines; CVCL_A036
|
|---|
| Biological sample resources |
BioSample; SAMN03151623
|
|---|
| Encyclopedic resources |
Wikidata; Q54994463
|
|---|
| Polymorphism and mutation databases |
Cosmic; 1086369
|
|---|
| Entry history |
|---|
| Entry creation | 06-Jun-2012 |
|---|
| Last entry update | 05-Oct-2023 |
|---|
| Version number | 26 |
|---|